Parnell Pharmaceuticals Holdings Ltd PARNF
AUD0.08
Last Updated: Feb 06, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Parnell Pharmaceuticals Holdings Ltd. Stock Analysis PARNF
United States Health Care Nano Cap Parnell Pharmaceuticals Holdings Ltd. is a veterinary pharmaceutical company, which engages in the development, manufacture, and commercialization of animal health solutions. The company is headquartered in Mascot, New South Wales. The company went IPO on 2014-06-18. The firm operates sterile manufacturing facilities and offers digital technology platforms that integrate with the Company’s products to offer veterinarians and animal owners superior solutions for their animal health needs. The firm also provides a fully integrated animal health platform. The Company’s mySYNCH is a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. The Company’s products include GONAbreed, estroPLAN, and RESPIRmycin. GONAbreed is used for the treatment of cystic ovaries and used in cattle synchronization protocols. The estroPLAN is used in animals with unobserved or non-detected estrus in cattle undergoing synchronization protocols. The RESPIRmycin is used for the treatment of respiratory disease in beef and non-lactating dairy cattle.
Parnell Pharmaceuticals Holdings Ltd (PARNF) Chart
Financial Metrics & Statements of Parnell Pharmaceuticals Holdings Ltd (PARNF)
FAQ's for Parnell Pharmaceuticals Holdings Ltd (PARNF)
- As of August 2026, Parnell Pharmaceuticals Holdings Ltd PARNF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Parnell Pharmaceuticals Holdings Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Parnell Pharmaceuticals Holdings Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Parnell Pharmaceuticals Holdings Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Parnell Pharmaceuticals Holdings Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Parnell Pharmaceuticals Holdings Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Parnell Pharmaceuticals Holdings Ltd (PARNF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
